Should We Limit Antiarrhythmic Drug Choice in Patients With Left
Ventricular Hypertrophy?
- Gerald Naccarelli
, - Peter Kowey
Gerald Naccarelli
Penn State Health Milton S Hershey Medical Center
Corresponding Author:gnaccarelli@pennstatehealth.psu.edu
Author Profile30 Oct 2022Submitted to Journal of Cardiovascular Electrophysiology 31 Oct 2022Submission Checks Completed
31 Oct 2022Assigned to Editor
31 Oct 2022Review(s) Completed, Editorial Evaluation Pending
31 Oct 2022Editorial Decision: Accept
09 Nov 2022Published in Journal of Cardiovascular Electrophysiology. 10.1111/jce.15732 
